Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Atkinson

Showing results (81-90 of 374) with videos related to

Pageof 38
Sort By:
Arthritis Research & Therapy|April 10, 2013
The granulocyte colony stimulating factor pathway regulates autoantibody production in a murine induced model of systemic lupus erythematosusMargareta Lantow, Ramya Sivakumar, Leilani Zeumer, et al.
Journal of Autoimmunity|May 20, 2003
Type 1 diabetes alters anti-hsp90 autoantibody isotypeHui-Yu Qin, Jeffrey L Mahon, Mark A Atkinson, et al.
Journal of Experimental Psychology. Human Perception and Performance|May 31, 2017
Are goal states represented during kinematic imitation?Geoff G Cole, Mark A Atkinson, Antonia D C D'Souza, et al.
Diabetes|April 28, 2005
Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetesTodd M Brusko, Clive H Wasserfall, Michael J Clare-Salzler, et al.
Experimental Hematology|March 25, 2008
Autologous umbilical cord blood infusion for type 1 diabetesMichael J Haller, Hilla-Lee Viener, Clive Wasserfall, et al.
Plos One|December 4, 2009
Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulationTodd M Brusko, Clive H Wasserfall, Maigan A Hulme, et al.
STAR Protocols|July 26, 2021
ACE2 chromogenic immunostaining protocol optimized for formalin-fixed paraffin-embedded human tissue sectionsMarda Jorgensen, Paul Joseph, Amanda L Posgai, et al.
The Lancet. Diabetes & Endocrinology|August 2, 2021
Defining a cure for type 1 diabetes: a call to actionBart O Roep, Enrique Montero, René van Tienhoven, et al.
Diabetes Care|November 6, 2025
Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on TeplizumabChantal Mathieu, Emily K Sims, Lucienne Chatenoud, et al.
FEBS Letters|October 15, 2005
Glucose transporter-2 (GLUT2) promoter mediated transgenic insulin production reduces hyperglycemia in diabetic miceBrant R Burkhardt, Mathew J Parker, Y Clare Zhang, et al.
Pageof 38

Showing results (81-90 of 374) with videos related to

Sort By:
Pageof 38
Arthritis Research & Therapy|April 10, 2013
The granulocyte colony stimulating factor pathway regulates autoantibody production in a murine induced model of systemic lupus erythematosusMargareta Lantow, Ramya Sivakumar, Leilani Zeumer, et al.
Journal of Autoimmunity|May 20, 2003
Type 1 diabetes alters anti-hsp90 autoantibody isotypeHui-Yu Qin, Jeffrey L Mahon, Mark A Atkinson, et al.
Journal of Experimental Psychology. Human Perception and Performance|May 31, 2017
Are goal states represented during kinematic imitation?Geoff G Cole, Mark A Atkinson, Antonia D C D'Souza, et al.
Diabetes|April 28, 2005
Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetesTodd M Brusko, Clive H Wasserfall, Michael J Clare-Salzler, et al.
Experimental Hematology|March 25, 2008
Autologous umbilical cord blood infusion for type 1 diabetesMichael J Haller, Hilla-Lee Viener, Clive Wasserfall, et al.
Plos One|December 4, 2009
Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulationTodd M Brusko, Clive H Wasserfall, Maigan A Hulme, et al.
STAR Protocols|July 26, 2021
ACE2 chromogenic immunostaining protocol optimized for formalin-fixed paraffin-embedded human tissue sectionsMarda Jorgensen, Paul Joseph, Amanda L Posgai, et al.
The Lancet. Diabetes & Endocrinology|August 2, 2021
Defining a cure for type 1 diabetes: a call to actionBart O Roep, Enrique Montero, René van Tienhoven, et al.
Diabetes Care|November 6, 2025
Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on TeplizumabChantal Mathieu, Emily K Sims, Lucienne Chatenoud, et al.
FEBS Letters|October 15, 2005
Glucose transporter-2 (GLUT2) promoter mediated transgenic insulin production reduces hyperglycemia in diabetic miceBrant R Burkhardt, Mathew J Parker, Y Clare Zhang, et al.
Pageof 38